CLSN News and Press, Celsion Corporation From 03/01/21

Today, we revisit biotech concern Celsion Corporation for the first time in over a half-decade. The stock still trades right near the $2 level just like it did when we last took a look at this small-cap name in 2015. News flow in 2021 has picked up, so it's time to circle back on ...

Are These On Your List Of Penny Stocks To Buy This Week? Love it or hate it, Robinhood and the popular penny stocks on the platform continue generating attention. The app and its founders came under fire recently amid the big GameStop (NYSE: GME ) short squeeze. While ma...

LAWRENCEVILLE, N.J., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that management will be holding one-on-one meetings with investor...

4 Biotech Penny Stocks To Watch Heading Into March 2021 Like any good investor, the key to picking penny stocks to buy is a proper balance between speculation and research. While this applies heavily to biotech penny stocks, there are some additional factors to take into consideration. ...

Celsion (CLSN) provides an update on its Phase I/II OVATION 2 Study with GEN-1 in patients with advanced ovarian cancer, including interim observations.The company said it has now enrolled about one-third, or 34 patients, of the anticipated 110 patients to be enrolled into the study, of ...

Of 27 patients who completed interval debulking surgery, 80% of those treated with GEN-1 had an R0 resection compared with 58% of control patients, a 38% improvement To date 34 patients, or approximately one-third of the total, have been enrolled at 22 sites, including 20 patients...

Non-Dilutive Funding Strengthens Balance Sheet; Extends Current Operating Runway to Over Three Years LAWRENCEVILLE, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical stage development company focused on DNA based immunotherapy and next g...

Gainers: ReTo Eco-Solutions (RETO) +93%.Celsion (CLSN) +62%.Rodgers Silicon Valley Acquisition (RSVA) +49%.Taoping (TAOP) +44%.RealNetworks (RNWK) +32%.Cooper Tire & Rubber (CTB) +30%.MICT (MICT) +26%.Conformis (CFMS) +26%.ATIF Holdings (ATIF) +25%.Vuzix (VUZI) +23%.Losers:...

Gainers: Celsion (CLSN) +54%, SunLink Health Systems (SSY) +27%, Citius Pharmaceuticals (CTXR) +26%, Can-Fite BioPharma (CANF) +19%, Aesthetic Medical International Holdings Group (AIH) +18%.Losers: Otonomy (OTIC) -43%, Brainstorm Cell Th...

ReTo Eco-Solutions (RETO) +132%.ATIF Holdings Limited (ATIF) +70% on establishing SPAC department to plan establishment of SPAC.Xcel Brands  (XELB) +52%.Celsion Corporation (CLSN) +48% after receiving FDA fast track designation for GEN-1.Can-Fite BioPharma (CANF) +28% on p...